Next Article in Journal
A Fast, Stability-Indicating, and Validated Liquid Chromatography Method for the Purity Control of Lercanidipine Hydrochloride in Tablet Dosage Form
Previous Article in Journal
Synthesis, Structural Elucidation, and In Vitro Antitumor Activities of Some Pyrazolopyrimidines and Schiff Bases Derived from 5-Amino-3-(arylamino)-1H-pyrazole-4-carboxamides
 
 
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Development and Validation of a UPLC Method by the QbD-Approach for the Estimation of Rabeprazole and Levosulpiride from Capsules

*
Author to whom correspondence should be addressed.
Sci. Pharm. 2014, 82(2), 307-326; https://doi.org/10.3797/scipharm.1310-17
Submission received: 21 October 2013 / Accepted: 16 January 2014 / Published: 16 January 2014

Abstract

Statistical experimental design was used to optimize the chromatographic separations of two pharmaceutical compounds from their respective potential impurities. A fractional factorial design was utilized to study the effects of pH, organic solvent in mobile phases A&B, and flow rate on the resolution of Rabeprazole and Rabeprazole Sulfone, which had closely eluting peaks. A desirability function applied to the optimized conditions predicted the peak resolution between 2.2 and 2.7 for the Rabeprazole & Rabeprazole Sulfone impurity. The chromatographic method employed an Acquity UPLC, BEH C18 column (100 x 2.1 mm i.d., 1.7 μm particle size) with the mobile phase consisting of a phosphate buffer, pH 6.5, and acetonitrile in a gradient program. The flow rate and injection volumes were 0.45 mL/min & 5 μl, respectively, and detection was done at 254 nm. The chromatographic method was validated for linearity, accuracy, precision, specificity, and ruggedness according to ICH guidelines. The results clearly showed that the quality by design concept could be effectively applied to optimize a UPLC chromatographic method with fewer trials and error-free experimentation.
Keywords: Rabeprazole sodium; Levosulpiride; UPLC; Method Validation; Experimental design Rabeprazole sodium; Levosulpiride; UPLC; Method Validation; Experimental design

Share and Cite

MDPI and ACS Style

THUMMALA, V.R.R.; SESHADRI, R.K.; THARLAPU, S.S.J.M.; IVATURI, M.R.; NITTALA, S.R. Development and Validation of a UPLC Method by the QbD-Approach for the Estimation of Rabeprazole and Levosulpiride from Capsules. Sci. Pharm. 2014, 82, 307-326. https://doi.org/10.3797/scipharm.1310-17

AMA Style

THUMMALA VRR, SESHADRI RK, THARLAPU SSJM, IVATURI MR, NITTALA SR. Development and Validation of a UPLC Method by the QbD-Approach for the Estimation of Rabeprazole and Levosulpiride from Capsules. Scientia Pharmaceutica. 2014; 82(2):307-326. https://doi.org/10.3797/scipharm.1310-17

Chicago/Turabian Style

THUMMALA, Veera Raghava Raju, Raja Kumar SESHADRI, Satya Sankarsana Jagan Mohan THARLAPU, Mrutyunjaya Rao IVATURI, and Someswara Rao NITTALA. 2014. "Development and Validation of a UPLC Method by the QbD-Approach for the Estimation of Rabeprazole and Levosulpiride from Capsules" Scientia Pharmaceutica 82, no. 2: 307-326. https://doi.org/10.3797/scipharm.1310-17

Article Metrics

Back to TopTop